{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:43:20Z","timestamp":1791467000714,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008532","name":"Universidade Federal do Rio Grande do Norte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008532","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017478","name":"Usona Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.euroneuro.2025.06.002","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T14:00:51Z","timestamp":1750168851000},"page":"16-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1653-2565","authenticated-orcid":false,"given":"Isabel","family":"Wie\u00dfner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7407-880X","authenticated-orcid":false,"given":"Marcelo","family":"Falchi-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Laborde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handersson","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raynara","family":"Bolcont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0677-0439","authenticated-orcid":false,"given":"S\u00e9rgio","family":"Ruschi Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3649-6207","authenticated-orcid":false,"given":"\u00c9rica","family":"Pantrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3105-9637","authenticated-orcid":false,"given":"Melanie","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via","family":"Arichelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3687-8790","authenticated-orcid":false,"given":"Raissa","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana","family":"Aires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9378-0259","authenticated-orcid":false,"given":"Luis Fernando","family":"Nunes Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8179-735X","authenticated-orcid":false,"given":"Lu\u00edsa","family":"Dantas Corr\u00eaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rom\u00e1ria B\u00e1rbara","family":"Da Costa Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaike","family":"Thie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natan","family":"Silva-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Antonio","family":"de Ara\u00fajo Costa Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5967-1172","authenticated-orcid":false,"given":"Marcos Vin\u00edcius","family":"Jales Lima de Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4887-8635","authenticated-orcid":false,"given":"Nicole","family":"Galv\u00e3o-Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Draulio","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1612-6703","authenticated-orcid":false,"given":"Fernanda","family":"Palhano-Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2025.06.002_bib0001","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1021\/acsptsci.1c00014","article-title":"Predicting reactions to psychedelic drugs: a systematic review of states and traits related to acute drug effects","volume":"4","author":"Aday","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0002","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/acps.13249","article-title":"Therapeutic effects of classic serotonergic psychedelics: a systematic review of modern-era clinical studies","volume":"143","author":"Andersen","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0003","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fnins.2018.00536","article-title":"N, N-dimethyltryptamine (DMT), an endogenous hallucinogen: past, present, and future research to determine its role and function","volume":"12","author":"Barker","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0004","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0269881115609019","article-title":"Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin","volume":"29","author":"Barrett","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0005","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/02698811241276788","article-title":"Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being","volume":"38","author":"Bonnelle","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0006","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hup.2545","article-title":"Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens","volume":"31","author":"Bouso","year":"2016","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0007","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N,N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0008","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0269881118754710","article-title":"Psychedelics and the essential importance of context","volume":"32","author":"Carhart-Harris","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1485337","article-title":"Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics","volume":"15","author":"Chaves","year":"2024","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2024_562","article-title":"Phenomenology of psychedelic experiences and psychedelic-associated distressing effects: quantifying subjective experiences","author":"Costines","year":"2024","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0011","series-title":"5D-ASC: Questionnaire For the Assessment of Altered States of consciousness. Short Introduction","author":"Dittrich","year":"2010"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0012","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/s41386-022-01344-y","article-title":"Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder","volume":"47","author":"D\u2019Souza","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0013","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41386-024-02041-8","article-title":"Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants","volume":"50","author":"Erne","year":"2025","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0014","article-title":"The antidepressant effects of vaporized N,N-dimethyltryptamine: an open-label pilot trial in treatment-resistant depression","author":"Falchi-Carvalho","year":"2024","journal-title":"Psychedelic Med."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0015","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41386-025-02091-6","article-title":"Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression","volume":"50","author":"Falchi-Carvalho","year":"2025","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.euroneuro.2023.12.006","article-title":"Safety and tolerability of inhaled N,N-dimethyltryptamine (BMND01 candidate): a phase I clinical trial","volume":"80","author":"Falchi-Carvalho","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0017","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/0269881116677852","article-title":"Set and setting, psychedelics and the placebo response: an extra-pharmacological perspective on psychopharmacology","volume":"30","author":"Hartogsohn","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0018","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41386-023-01588-2","article-title":"Dose-response relationships of LSD-induced subjective experiences in humans","volume":"48","author":"Hirschfeld","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0019","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/0269881121992676","article-title":"Dose-response relationships of psilocybin-induced subjective experiences in humans","volume":"35","author":"Hirschfeld","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0021","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41386-023-01607-2","article-title":"Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants","volume":"48","author":"Ley","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0022","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/02698811231196877","article-title":"Psychological and physiological effects of extended DMT","volume":"38","author":"Luan","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0023","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1468-5906.2012.01685.x","article-title":"Factor analysis of the mystical experience questionnaire: a study of experiences occasioned by the hallucinogen psilocybin","volume":"51","author":"MacLean","year":"2012","journal-title":"J. Sci. Study Relig."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0024","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1590\/S0101-60832011000600004","article-title":"Hallucinogen Rating Scale (HRS) - A Brazilian version: translation and cross-cultural adaptation","volume":"38","author":"Mizumoto","year":"2011","journal-title":"Rev. Psiquiatr. Clin."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0025","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/17512433.2021.1933434","article-title":"Blinding and expectancy confounds in psychedelic randomized controlled trials","volume":"14","author":"Muthukumaraswamy","year":"2021","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0026","article-title":"Serotonin 5-HT(2A) receptor function as a contributing factor to both neuropsychiatric and cardiovascular diseases","volume":"2009","author":"Nichols","year":"2009","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0027","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.760671","article-title":"A phase 1, dose-ranging study to assess safety and psychoactive effects of a vaporized 5-methoxy-N, N-dimethyltryptamine formulation (GH001) in healthy volunteers","volume":"12","author":"Reckweg","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1133414","article-title":"A phase 1\/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression","volume":"14","author":"Reckweg","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0030","doi-asserted-by":"crossref","unstructured":"Rosas, F.E., Mediano, P.A.M., Timmermann, C., Luppi, A.I., Candia-Rivera, D., Abbasi-Asl, R., Gazzaley, A., Kringelbach, M.L., Muthukumaraswamy, S., Bor, D., Garfinkel, S., Carhart-Harris, R.L., 2023. The entropic heart: tracking the psychedelic state via heart rate dynamics. bioRxiv. https:\/\/doi.org\/10.1101\/2023.11.07.566008.","DOI":"10.1101\/2023.11.07.566008"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0031","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00413244","article-title":"The effect of n,n-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide","volume":"5","author":"Rosenberg","year":"1964","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/0101-60830000000105","article-title":"Translation and cultural adaptation of the States of Consciousness Questionnaire (SOCQ) and statistical validation of the mystical experience questionnaire (MEQ30) in Brazilian Portuguese","volume":"44","author":"Schenberg","year":"2017","journal-title":"Arch. Clin. Psychiatry (S\u00e3o Paulo)"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0033","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0166-4328(96)00081-2","article-title":"Human psychopharmacology of N,N-dimethyltryptamine","volume":"73","author":"Strassman","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0034","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","article-title":"Dose-response study of N,N-dimethyltryptamine in humans: II. Subjective effects and preliminary results of a new rating scale","volume":"51","author":"Strassman","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012412","article-title":"Psychometric evaluation of the altered states of consciousness rating scale (OAV)","volume":"5","author":"Studerus","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0037","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51974-4","article-title":"Neural correlates of the DMT experience assessed with multivariate EEG","volume":"9","author":"Timmermann","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0038","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-021-05817-8","article-title":"A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats","author":"Uthaug","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0039","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41398-023-02477-4","article-title":"Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants","volume":"13","author":"Vogt","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0040","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0041","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1017\/S0033291721002531","article-title":"LSD, madness and healing: mystical experiences as possible link between psychosis model and therapy model","volume":"53","author":"Wie\u00dfner","year":"2023","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2025.06.002_bib0042","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s44159-024-00345-6","article-title":"Clinically relevant acute subjective effects of psychedelics beyond mystical experience","volume":"3","author":"Yaden","year":"2024","journal-title":"Nat. Rev. Psychol."}],"updated-by":[{"DOI":"10.1016\/j.euroneuro.2026.112830","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X25001129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X25001129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:56:39Z","timestamp":1776160599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X25001129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":41,"alternative-id":["S0924977X25001129"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2025.06.002","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2025.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. and ECNP. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}